Elite Pharmaceuticals, Inc.
ELTP
$0.37
$0.00-0.62%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.80M | 21.09M | 26.62M | 21.74M | 11.32M |
| Total Receivables | 59.72M | 48.53M | 40.87M | 36.22M | 29.21M |
| Inventory | 21.26M | 25.10M | 18.16M | 19.36M | 16.24M |
| Prepaid Expenses | 1.33M | 2.07M | 139.50K | 547.90K | 976.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 112.11M | 96.79M | 85.79M | 77.86M | 57.74M |
|
|
|||||
| Total Current Assets | 112.11M | 96.79M | 85.79M | 77.86M | 57.74M |
| Net Property, Plant & Equipment | 13.01M | 13.10M | 13.40M | 13.81M | 14.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | 289.00K | 289.00K | 289.00K | 289.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.18M | 16.23M | 17.76M | 19.38M | 24.26M |
| Total Assets | 138.29M | 126.41M | 117.25M | 111.34M | 96.39M |
|
|
|||||
| Total Accounts Payable | 6.05M | 6.52M | 3.42M | 5.09M | 2.96M |
| Total Accrued Expenses | 9.60M | 4.75M | 5.88M | 3.83M | 3.45M |
| Short-term Debt | -- | -- | -- | -- | 4.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.14M | 1.12M | 1.10M | 1.09M | 1.08M |
| Total Finance Division Other Current Liabilities | 594.20K | 802.30K | 268.30K | 755.60K | 346.20K |
| Total Other Current Liabilities | 594.20K | 802.30K | 268.30K | 755.60K | 346.20K |
| Total Current Liabilities | 17.39M | 13.19M | 10.67M | 10.76M | 11.84M |
|
|
|||||
| Total Current Liabilities | 17.39M | 13.19M | 10.67M | 10.76M | 11.84M |
| Long-Term Debt | 2.80M | 2.83M | 2.84M | 3.01M | 3.03M |
| Short-term Debt | -- | -- | -- | -- | 4.00M |
| Capital Leases | 1.87M | 2.11M | 2.36M | 2.57M | 2.80M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 17.34M | 27.97M | 39.79M | 47.31M | 25.20M |
| Total Liabilities | 39.41M | 46.10M | 55.66M | 63.66M | 42.87M |
|
|
|||||
| Common Stock & APIC | 175.02M | 174.91M | 174.78M | 174.58M | 174.53M |
| Retained Earnings | -75.83M | -94.29M | -112.89M | -126.59M | -120.70M |
| Treasury Stock & Other | -306.80K | -306.80K | -306.80K | -306.80K | -306.80K |
| Total Common Equity | 98.88M | 80.31M | 61.59M | 47.68M | 53.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 98.88M | 80.31M | 61.59M | 47.68M | 53.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 98.88M | 80.31M | 61.59M | 47.68M | 53.52M |
|
|
|||||